Skip to main content
You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!
BIO's final comments on FDA Draft Guidances on Risk Management
Share
Print
Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment.
Read BIO's comments (193 KB PDF)
20040702Pharmacovigilance.pdf
Popular Articles
BIO lauds House of Representatives for "Moving FDA in New Direction" with passage of H.R. 1411
BIO Calls on President Clinton to Sign FDA Reform Bill Into Law
BIO Looks Forward to Implementation of FDA Reforms
BIO President Addresses FDA on PDUFA
House Passes Bioterrorism/PDUFA Legislation in 425-1 Vote
Popular Articles
International Market Access
Preparing for BIO
Podcasts to Check Out
Leaders In Science, Advocacy, Media To Judge 2010 Biotech Humanitarian Award
ISO: Biotech Humanitarian